A short post urging careful screening and ongoing support before GLP-1 drugs are used by anyone with past eating disorders.
Recap by typeshit. Post by Facebook on Facebook.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
No obesity drugs or surgery for kids under 10, the WHO says. Medication and surgery may be considered for some adolescents when lifestyle changes fail.
Host Morgan Sung talks with UCSF dermatologist Dr. Sungat Grewal, who warns of real risks from the unapproved Barbie peptide, plus STAT's Sarah Todd on MAHA.
Loading…